Adverse Event Reporting
| VAERS ID | 2194885 |
|---|---|
| Gender | Male |
| Age | 90 |
| StateCode | WI |
| Pharmaceutical Company | PFIZER\BIONTECH |
| Lot Number | EN6198 |
| Number of vaccinations | 2 |
| Vaccinated | 2021-02-19 |
| Onset | 2022-03-17 |
| Condition | Hospitalized Died |
Symptoms
- Pyrexia
- Dyspnoea
- Chest X-ray abnormal
- Oxygen saturation decreased
- COVID-19
- Lymphocyte count increased
- SARS-CoV-2 antibody test positive
- Full blood count abnormal
- Death
- Hypoxia
- Pleural effusion
- Lung opacity
- Blood gases
- Bacterial test negative
- Differential white blood cell count abnormal
- Aspiration pleural cavity
- Cytology normal
- Monocytosis
- Pneumonia bacterial
- Flow cytometry
- Smear buccal abnormal
- Positive airway pressure therapy
Current Illness
unknown
Preexisting Conditions
unknown
Other Medications
unknown
Previous Vaccinations
Allergies
unknown
Laboratory Data
Labs: including bacterial studies and cytology Chest Xray Thoracentesis
Write-up
Patient was vaccinated with Pfizer covid-19 vaccine on 1/29/21 and 2/19/21.
On 3/17/2022 patient was scheduled for an outpatient CT-guided pleural biopsy.
When the patient arrived for the procedure, he was found to have a low-grade temp of 100.
5 °F and hypoxic on room air desaturating into the mid to upper 80s.
noted oxygen saturation improved with application of 2 L of oxygen.
He was sent to the ED for further evaluation.
In the ED he was again found to be hypoxic down to 85% on room air.
Chest x-ray was obtained and notable for progressive multifocal bilateral airspace opacity and a small right pleural effusion.
Patient was evaluated for suspected secondary bacterial pneumonia.
Patient had been previously hospitalized on 3/6/2022 through 3/8/2022.
Covid antibody was obtained on 3/7/2022 and came back positive.
Patient had had COVID-19 for at least 10 to 14 days at that time.
Per web report, based on that information patient is at least 20 days out from initial infection.
He has not had leukocytosis.
Patient had a right-sided thoracentesis for recurrent right-sided pleural effusion on 3/7/2022.
Bacterial studies were negative.
Cytology was negative for malignant cells.
Flow cytometry was added on and pathologist contacted the hospitalist team on 3/8/2022.
A peripheral smear was also reported to have increased smudge cells.
The CBC differential indicated he continues to have lymphocyte predominance along with monocytosis.
Report indicated patient became increasingly short of breath and patient was hardly maintaining a saturation of 90%.
Patient?s breathing was then labored, RR low 30s, and patient complained of dyspnea.
Patient was asked about intubation.
patient stated he is not sure if he wanted that and would like to think about it.
Stat CXR, ABGs.
Patient was place on bipap.
Per report it was noted: RN was notified that patient had a rhythm change.
RN found patient already passed away.
Time of death noted as 03:37.